GlaxoSmithKline PLC’s decision to potentially divest the popular malted milk drink Horlicks, which is largely sold through its publicly listed Indian subsidiary,GlaxoSmithKline Consumer Healthcare, isn’t about market-related pressures, the UK multinational’s top brass has emphasized.
“I want to be absolutely clear that this has, for a long time, been a winning and performing brand, primarily...